Emerging biomarkers in cardiometabolic disease

The epidemiological association between diabetes and heart failure is well-established and the two entities are emerging as global threats, both individually and synergistically, to an aging population. The exploration of multiple
proteins can shed light on pathophysiological pathways in both diabetes and cardiovascular disease. This can possibly provide novel diagnostic, prognostic and hopefully therapeutic implications.
The overall aim of this dissertation was to explore novel biomarkers in cardiometabolic disease especially in heart failure.